Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Patent
1991-05-20
1994-07-26
Springer, David B.
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
548251, 548252, 548253, C07D40302, C07D47104, A61K 3141, A61K 31415
Patent
active
053328205
ABSTRACT:
Novel substituted dibenzobicyclo[2.2.2]octanes of formula I, which are useful as angiotensin II antagonists, are disclosed: ##STR1##
REFERENCES:
patent: 3772315 (1973-11-01), Regel et al.
patent: 4207324 (1980-06-01), Matsumura et al.
patent: 4226878 (1980-10-01), Iizuka et al.
patent: 4226948 (1980-10-01), Popoff et al.
patent: 4340598 (1982-07-01), Furukawa et al.
patent: 4355040 (1982-10-01), Furukawa et al.
patent: 4379927 (1983-04-01), Vorbruggen et al.
patent: 4448781 (1984-05-01), Cross et al.
Torii et al., Metabolism and Disposition of 4-Chloro-1-(4-methoxy-3-methylbenzyl)-2-phenylimidazole-5-acetic Acid (CV-2973), a New Hypotensive Agent with Diuretic Activity, in Rats and Dogs, J. Takeda Res. Lab., vol. 41, No. 3/4, pp. 181-191(1982).
Pals et al., Role of the Pressor Action of Angiotensin II in Experimental Hypertension, Circulation Research, vol. XXIX, Dec. 1971, pp. 673-681.
Streeten et al., 8. Angiotensin-receptor blocking drugs, Handbook of Hypertension, vol. 5, Clinical Pharmacology of Antihypertensive Drugs, pp. 246-271 (1984).
Keeton et al., The Pharmacologic Alteration of Renin Release, Pharmacological Reviews, vol. 31, No. 2, pp. 81-227 (1981).
Myron H. Weinberger MD, Angiotensin-Converting Enzyme Inhibitors, Medical Clinics of North America, vol. 71, No. 5, pp. 979-991, Sep. 1987.
Dunn, Clinical Effects of Prostaglandins in Renal Disease, Reprinted from Hospital Practice, Mar. 1984, vol. 19, No. 3, pp. 99-113.
Satoh et al., Influence of the Renin-Angiotensin System on the Effect of Prostaglandin Synthesis Inhibitors in the Renal Vasculature, Supplement I to Circulation Research, vols. 36 and 37, pp. I-89 through I-96, Jun. 1975.
Blasingham et al., Differential renal effects of cyclooxygenase inhibition in sodium-replete and sodium-deprived dog, 1980 the American Physiological Society, pp. F360-F365.
Wong et al., Mechanism of Captopril-Induced Renal Vasodilatation in Anesthetized Dogs after Nonhypotensive Hermorrhage, The Journal of Pharmacology and Experimental Therapeutics, pp. 104-109, accepted for publication Jun. 30, 1980.
E. I. Du Pont de Nemours and Company
Springer David B.
LandOfFree
Dibenzobicyclo(2.2.2) octane angiotensin II antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dibenzobicyclo(2.2.2) octane angiotensin II antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dibenzobicyclo(2.2.2) octane angiotensin II antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1053955